Evidence map›Paper›PMID 40690256›Full record

ArticleAnalytical chemistry2025

Gas Phase Separation of Modified Peptides for Activity-Based Protein Profiling.

Peter Bellotti, Zirong Chen, Charles D Warren, Jacob B Geri

Abstract read
In one paragraph

Article in Analytical chemistry, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Peter BellottiDepartment of Pharmacology, Weill Cornell Medicine, Cornell University, New York, New York 10065, United States.
Zirong ChenDepartment of Pharmacology, Weill Cornell Medicine, Cornell University, New York, New York 10065, United States.
Charles D WarrenDepartment of Pharmacology, Weill Cornell Medicine, Cornell University, New York, New York 10065, United States.
Jacob B GeriDepartment of Pharmacology, Weill Cornell Medicine, Cornell University, New York, New York 10065, United States.ORCID 0000-0002-9215-5610

Funding

Supplement for Optically Gated Discovery of Protein-Biomolecule Interactions project.R35GM147449 · NIGMS · WEILL MEDICAL COLL OF CORNELL UNIV · PI Jacob Geri · 2022 to 2026
$2.4M
NIGMS NIH HHS R35 GM147449
6 · The paper itself

Abstract

Profiling the reactivity of the proteome with amino-acid level resolution requires the identification and quantification of reacted peptides in the presence of abundant unmodified peptides. Affinity-based approaches use solid sorbents such as streptavidin beads to enrich modified peptides in a solution but are step-intensive and suffer from analyte losses. Here, we describe timShift, a gas phase, in-spectrometer approach for enhanced reactive amino acid profiling, which exploits modification-induced alteration of peptide physical properties. A dicationic, aerodynamic, cysteine-reactive reagent increases the ion mobility of labeled peptides, physically separating them from unmodified 1

Indexed as

GasesPeptidesProteomicsCysteinePhase SeparationCysteineGasesPeptides

Identifiers

PMID40690256
PMCPMC13068103

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.